Stockscreener 앱 받기
3.78
0.00%
0.00
전일 마감가:
$3.78
열려 있는:
$3.82
하루 거래량:
728.13K
Relative Volume:
0.56
시가총액:
$291.77M
수익:
-
순이익/손실:
$-45.62M
주가수익비율:
-6.3594
EPS:
-0.5944
순현금흐름:
$-62.34M
1주 성능:
+8.62%
1개월 성능:
+23.13%
6개월 성능:
-6.20%
1년 성능:
+21.94%
1일 변동 폭
$3.73
$3.86
1주일 범위
$3.28
$3.88
52주 변동 폭
$1.35
$4.60
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
명칭
Eledon Pharmaceuticals Inc
전화
949-238-8090
주소
19800 MACARTHUR BLVD., IRVINE
Compare ELDN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
3.78 | 291.77M | 0 | -45.62M | -62.34M | -0.5944 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-18 | 재개 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Guggenheim | Buy |
| 2022-05-13 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-03-23 | 개시 | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc 주식(ELDN)의 최신 뉴스
[S-3] Eledon Pharmaceuticals, Inc. Shelf Registration Statement - Stock Titan
SEC Form DEFA14A filed by Eledon Pharmaceuticals Inc. - Quantisnow
[ARS] Eledon Pharmaceuticals, Inc. SEC Filing - Stock Titan
Major share authorization increase on ballot in Eledon (NASDAQ: ELDN) 2026 proxy - Stock Titan
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026 - The Manila Times
NewcelX and Eledon Pharmaceuticals Collaborate on NCEL-101 for Type 1 Diabetes, Reporting Strong Financial Position and Strategic Growth Plans - Quiver Quantitative
NewcelX Reports Financial Results for 2025 and Provides Shareholders With Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration With Eledon Pharmaceuticals in 2026 - 富途牛牛
EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug - Sahm
Eledon Pharmaceuticals (ELDN) Price Target Decreased by 14.93% to 8.33 - MSN
We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment - Healthcare Brew
BlackRock (NYSE) reports 4.38M-share stake in Eledon (ELDN) - Stock Titan
Eledon Pharmaceuticals drops 10% on stock offering - MSN
ELDN Price Today: Eledon Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Eledon Pharmaceuticals (NASDAQ: ELDN) proposes 450M-share authorization increase - Stock Titan
Eledon Pharmaceuticals (ELDN) Partners with NewcelX to Enhance D - GuruFocus
5 Unstoppable Stocks That Could Double Your Money - Insider Monkey
Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money - Insider Monkey
NewcelX Ltd. Enhances Type 1 Diabetes Program with Strategic Collaboration with Eledon Pharmaceuticals - Quiver Quantitative
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference - marketscreener.com
NewcelX heads to Swiss Biotech with a Type 1 diabetes strategy - Stock Titan
We're Not Very Worried About Eledon Pharmaceuticals' (NASDAQ:ELDN) Cash Burn Rate - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Down 14.5% in March - MarketBeat
Big Picture: Can Eledon Pharmaceuticals Inc outperform under higher oil pricesWeekly Trade Review & AI Forecast for Swing Trade Picks - baoquankhu1.vn
EPS Watch: Is Eledon Pharmaceuticals Inc backed by strong institutional buyingWeekly Market Outlook & Short-Term Swing Trade Alerts - baoquankhu1.vn
SG Americas Securities LLC Makes New Investment in Eledon Pharmaceuticals, Inc. $ELDN - MarketBeat
Can Eledon Pharmaceuticals (ELDN) Stock Beat the Market | Price at $3.15, Up 3.11%High Conviction Picks - Xã Thanh Hà
Can Eledon Pharmaceuticals Inc expand its profit marginsMarket Movement Recap & Safe Capital Growth Plans - baoquankhu1.vn
Market Review: Can Eledon Pharmaceuticals Inc outperform under higher oil pricesRecession Risk & Reliable Intraday Trade Alerts - baoquankhu1.vn
Gainers Report: What hedge funds are buying Eledon Pharmaceuticals Inc2026 Trade Ideas & Safe Capital Growth Stock Tips - baoquankhu1.vn
After islet transplants, 10 diabetes patients stopped using insulin - Stock Titan
Insider Sell: Can Eledon Pharmaceuticals Inc outperform under higher oil pricesWeekly Stock Report & Technical Buy Zone Confirmations - baoquankhu1.vn
Eledon Pharmaceuticals Inc (2TK.SG) - Yahoo! Finance Canada
ELDN Forecast, Price Target & Analyst Ratings | ELEDON PHARMACEUTICALS INC (NASDAQ:ELDN) - ChartMill
Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Rises By 30.3% - marketbeat.com
Geopolitics Watch: What hedge funds are buying Eledon Pharmaceuticals Inc2026 News Drivers & Stepwise Trade Execution Plans - baoquankhu1.vn
Vanguard disaggregates holdings after realignment; Eledon (ELDN) showing 0 shares - Stock Titan
What is Noble Financial's Forecast for ELDN Q1 Earnings? - MarketBeat
Is Eledon Pharmaceuticals (NASDAQ:ELDN) In A Good Position To Deliver On Growth Plans? - Sahm
Midday Stock Roundup: RxSight Climbs 7% - Orange County Business Journal
Eledon Unveils New Type 1 Diabetes Data - Orange County Business Journal
Noble Financial Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Eledon Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings | 2TK | US28617K1016 - marketscreener.com
If You Invested $1,000 in Eledon Pharmaceuticals Inc (ELDN) - Stock Titan
LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Eledon Pharmaceuticals Reports Positive 2025 Results for Tegoprubart in Transplant Trials and Receives FDA Orphan Drug Designation - Minichart
Eledon Pharmaceuticals, Inc. 2026 Annual Report: Business Overview, Risk Factors, and Strategic Focus on Immunology and Tegoprubart Development 29 - Minichart
Eledon Pharmaceuticals (NASDAQ:ELDN) Announces Quarterly Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
ELEDON PHARMACEUTICALS ($ELDN) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Eledon Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Eledon Pharmaceuticals Inc (ELDN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):